Literature DB >> 9707604

Fas-independent death of activated CD4(+) T lymphocytes induced by CTLA-4 crosslinking.

P Scheipers1, H Reiser.   

Abstract

The CTLA-4 receptor is a critical inhibitory regulator of T cell proliferation and effector function. However, the mechanisms through which CTLA-4 modulates the activation of T cells remain uncertain. Initial studies, using activated human T cells, have suggested that CTLA-4 crosslinking may induce apoptosis. However, more recent experiments have demonstrated that crosslinking of the CTLA-4 receptor on the surface of resting murine T cells blocks cell cycle progression without inducing apoptosis. Here we provide evidence that CTLA-4 crosslinking on the surface of activated murine CD4(+) T lymphocytes leads to death of a substantial fraction of the cells whereas in resting CD4(+) T cells the same stimulation conditions induce cell cycle arrest without apoptosis. Cell death induced by CTLA-4 stimulation occurs independently of Fas and therefore may involve a novel pathway. CTLA-4-mediated apoptosis may be a means of terminating the function of previously stimulated T cells. Exploitation of this mechanism also may provide a therapeutic strategy to eliminate alloreactive or autoreactive T cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9707604      PMCID: PMC21465          DOI: 10.1073/pnas.95.17.10083

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  42 in total

1.  CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones.

Authors:  F A Harding; J G McArthur; J A Gross; D H Raulet; J P Allison
Journal:  Nature       Date:  1992-04-16       Impact factor: 49.962

2.  CTLA4 mediates antigen-specific apoptosis of human T cells.

Authors:  J G Gribben; G J Freeman; V A Boussiotis; P Rennert; C L Jellis; E Greenfield; M Barber; V A Restivo; X Ke; G S Gray
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-31       Impact factor: 11.205

3.  Differential T cell costimulatory requirements in CD28-deficient mice.

Authors:  A Shahinian; K Pfeffer; K P Lee; T M Kündig; K Kishihara; A Wakeham; K Kawai; P S Ohashi; C B Thompson; T W Mak
Journal:  Science       Date:  1993-07-30       Impact factor: 47.728

4.  Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome.

Authors:  G H Fisher; F J Rosenberg; S E Straus; J K Dale; L A Middleton; A Y Lin; W Strober; M J Lenardo; J M Puck
Journal:  Cell       Date:  1995-06-16       Impact factor: 41.582

5.  B70 antigen is a second ligand for CTLA-4 and CD28.

Authors:  M Azuma; D Ito; H Yagita; K Okumura; J H Phillips; L L Lanier; C Somoza
Journal:  Nature       Date:  1993-11-04       Impact factor: 49.962

6.  Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation.

Authors:  G J Freeman; J G Gribben; V A Boussiotis; J W Ng; V A Restivo; L A Lombard; G S Gray; L M Nadler
Journal:  Science       Date:  1993-11-05       Impact factor: 47.728

7.  Identification and distribution of the costimulatory receptor CD28 in the mouse.

Authors:  J A Gross; E Callas; J P Allison
Journal:  J Immunol       Date:  1992-07-15       Impact factor: 5.422

8.  Increased Fas antigen expression in murine retrovirus-induced immunodeficiency syndrome, MAIDS.

Authors:  K Hiromatsu; Y Aoki; M Makino; Y Matsumoto; T Mizuochi; Y Gotoh; K Nomoto; J Ogasawara; S Nagata; Y Yoshikai
Journal:  Eur J Immunol       Date:  1994-10       Impact factor: 5.532

9.  CTLA-4 is a second receptor for the B cell activation antigen B7.

Authors:  P S Linsley; W Brady; M Urnes; L S Grosmaire; N K Damle; J A Ledbetter
Journal:  J Exp Med       Date:  1991-09-01       Impact factor: 14.307

10.  Murine B7-2, an alternative CTLA4 counter-receptor that costimulates T cell proliferation and interleukin 2 production.

Authors:  G J Freeman; F Borriello; R J Hodes; H Reiser; J G Gribben; J W Ng; J Kim; J M Goldberg; K Hathcock; G Laszlo
Journal:  J Exp Med       Date:  1993-12-01       Impact factor: 14.307

View more
  28 in total

1.  The association of CTLA-4 and HLA class II autoimmune risk genotype with regulatory T cell marker expression in 5-year-old children.

Authors:  C-O Jonson; M Hedman; M Karlsson Faresjö; R Casas; J Ilonen; J Ludvigsson; O Vaarala
Journal:  Clin Exp Immunol       Date:  2006-07       Impact factor: 4.330

2.  Association between cytotoxic T-lymphocyte antigen-4 +49A/G polymorphism and colorectal cancer risk: a meta-analysis.

Authors:  Lei He; Tao Deng; He-Sheng Luo
Journal:  Int J Clin Exp Med       Date:  2015-03-15

3.  Cytotoxic T lymphocyte-associated antigen-4 +49A>G polymorphism and the risk of non-small cell lung cancer in a Chinese population.

Authors:  Hui-Ning Liu; Jian-Ling Su; Shao-Hui Zhou; Li-Jun Liu; Peng Qie
Journal:  Int J Clin Exp Med       Date:  2015-07-15

4.  Infliximab treatment induces apoptosis of lamina propria T lymphocytes in Crohn's disease.

Authors:  T ten Hove; C van Montfrans; M P Peppelenbosch; S J H van Deventer
Journal:  Gut       Date:  2002-02       Impact factor: 23.059

5.  CTLA-4 on alloreactive CD4 T cells interacts with recipient CD80/86 to promote tolerance.

Authors:  Josef Kurtz; Forum Raval; Casey Vallot; Jayden Der; Megan Sykes
Journal:  Blood       Date:  2009-01-29       Impact factor: 22.113

6.  CD4(+)CD25(+) regulatory T cells resist a novel form of CD28- and Fas-dependent p53-induced T cell apoptosis.

Authors:  Nagendra Singh; Mutsumi Yamamoto; Mariko Takami; Yoichi Seki; Mayuko Takezaki; Andrew L Mellor; Makio Iwashima
Journal:  J Immunol       Date:  2009-11-30       Impact factor: 5.422

7.  B7-1 mediated costimulation regulates pancreatic autoimmunity.

Authors:  Deepak Yadav; Cody Fine; Miyuki Azuma; Nora Sarvetnick
Journal:  Mol Immunol       Date:  2007-02-07       Impact factor: 4.407

Review 8.  Role of the CTLA-4 receptor in T cell activation and immunity. Physiologic function of the CTLA-4 receptor.

Authors:  P Scheipers; H Reiser
Journal:  Immunol Res       Date:  1998       Impact factor: 2.829

9.  Associations between CTLA-4 +49 A/G (rs231775) polymorphism and cancer risk: a meta-analysis based on 52 case-control studies.

Authors:  Lu Wang; Zhiwei Jiang; Hao Qiu; Weifeng Tang; Tanghai Duan; Lixin Wang
Journal:  Int J Clin Exp Med       Date:  2015-05-15

10.  Association between Cytotoxic T-lymphocyte antigen 4 (CTLA-4) +49 G>A (rs231775) polymorphism and esophageal cancer: from a case-control study to a meta-analysis.

Authors:  Chao Liu; Yafeng Wang; Heping Jiang; Weifeng Tang; Shuchen Chen; Mingqiang Kang; Changqing Dong; Haiyong Gu
Journal:  Int J Clin Exp Med       Date:  2015-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.